Logo

Sema4

GeneDx Q4 Revenues Grow 6 Percent but Miss Consensus Estimate

The firm reiterated an earlier forecast of $205 million to $220 million in revenues for 2023, representing a slight decline over 2022.

In Brief This Week: SD Biosensors, Meridian, Oncocyte, Opko Health, GeneDx, More

News items for the week of Jan. 30, 2023.

GeneDx to Raise $150M in Public and Direct Stock Offerings

Expected to close Jan. 31, the stock sales are intended to help the firm build up working capital, repay debts, and make strategic investments.

Rebranded GeneDx Bets Future on Whole-Exome, Whole-Genome Sequencing in Pediatric Rare Disease
Premium

After dropping underdeveloped Sema4 business lines but emphasizing the Centrellis informatics platform, the new GeneDx expects to reach profitability by 2025.

Sema4 Changes Name to GeneDx, Provides Preliminary 2022 Revenues, 2023 Guidance

As it exits reproductive health screening this quarter, the newly renamed GeneDx expects 2022 revenues of $170 million to $173 million and 2023 revenues of $205 million to $220 million in pursuit of profitability by 2025.

Jan 3, 2023

Sema4 Receives Nasdaq Noncompliance Warning, Will Return $42M Under Payor Lawsuit Settlement

Nov 14, 2022

Sema4 Exiting Reproductive Health Screening, Cutting 500 More Jobs in Latest Restructuring

Oct 31, 2022

SeqFirst Results Highlight Diagnostic Gains From Rapid Genome Sequencing in Critically Ill Newborns
Premium

Oct 6, 2022

GUARDIAN Study to Explore Newborn Screening by Genome Sequencing in 100K Babies in NYC
Premium

Oct 5, 2022

Sema4's GeneDx to Provide Genome Sequencing, Interpretation for Large-Scale Newborn Screening Study

Aug 16, 2022

Sema4 Cuts 13 Percent of Workforce, Exits Somatic Tumor Testing as Founder Schadt Departs
Premium

Jul 8, 2022

People in the News at New England Biolabs, Sema4, Guardant Health, More

Jun 17, 2022

People in the News at Quantum-Si, Cambridge Epigenetix, Sema4, More

Jun 1, 2022

Avera Health, Sema4 Launch Five-Year Precision Oncology Study

May 13, 2022

Sema4 Bullish on Future Following GeneDx Acquisition, Corporate Restructuring
Premium

May 12, 2022

Sema4 Q1 Revenues Decline 16 Percent

May 6, 2022

In Brief This Week: Sema4, Mirvie, Caris Life Sciences, Prenetics, 23andMe, More

May 6, 2022

People in the News at Congenica, Sema4, Centogene, More

Apr 8, 2022

In Brief This Week: Cardea Bio, Proof Diagnostics, Ginkgo Bioworks, Twist Bioscience, More

Mar 16, 2022

Sema4 to Study Precision Oncology Disparities in Nationwide Biobanking, Genomic Profiling Study

Mar 15, 2022

Sema4 Q4 Revenues Decline 10 Percent

Feb 22, 2022

Sema4, BioSymetrics Partner on Multiomic Drug Discovery

Jan 20, 2022

Sema4 to Embrace Co-CEO Model After $623M Acquisition of GeneDx
Premium

Jan 18, 2022

Sema4 to Acquire GeneDx for $623M

Jan 11, 2022

JPM Healthcare Conference Day 1: Seer, Twist, 10x, Guardant, Natera, Bruker, Adaptive, Qiagen, Sema4

Breaking News
The Scan

Genes Linked to White-Tailed Jackrabbits' Winter Coat Color Change

Climate change, the researchers noted in Science, may lead to camouflage mismatch and increase predation of white-tailed jackrabbits.

Adenine Base Editor Targets SCID Mutation in New Study

Researchers from the University of California, Los Angeles, report in Cell that adenine base editing was able to produce functional T lymphocytes in a model of severe combined immune deficiency.

Researchers Find Gene Affecting Alkaline Sensitivity in Plants

Researchers from the Chinese Academy of Science have found a locus affecting alkaline-salinity sensitivity, which could aid in efforts to improve crop productivity, as they report in Science.

International Team Proposes Checklist for Returning Genomic Research Results

Researchers in the European Journal of Human Genetics present a checklist to guide the return of genomic research results to study participants.